{"title":"单独使用二氧化碳血管造影在血管内修复破裂主动脉瘤的初步研究。","authors":"Gianluca Massaini, Tommaso Lazzarotto, Fabrizio Masciello, Simone Panci, Stefano Michelagnoli, Emiliano Chisci","doi":"10.1177/15266028231180995","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Endovascular aortic repair (EVAR) of a ruptured abdominal aortic aneurysm (rAAA) has become a common approach. Hemorrhagic shock associated with the use of iodinated contrast medium (ICM) increases the risk of acute kidney injury (AKI). Theoretically, eliminating ICM from EVAR can decrease that risk. The aim of this pilot study was to analyze the feasibility and safety of emergent EVAR performed with the exclusive use of carbon dioxide (CO<sub>2</sub>) for a rAAA.</p><p><strong>Methods: </strong>Since 2021, all consecutive rAAAs with hemorrhagic shock and suitable anatomical criteria for a standard endograft have been treated by EVAR with the exclusive use of CO<sub>2</sub> using an automated CO<sub>2</sub> injector (Angiodroid SpA, San Lazzaro di Savena, Italy).</p><p><strong>Results: </strong>Eight percutaneous EVARs were performed under local anesthesia. Median age was 78 (interquartile range [IQR]=6) years, 5 patients were male. The technical success was 100%, the 30-day mortality was 25% (n=2), the median amount of administered CO<sub>2</sub> was 400 (IQR=60) ml. The median change in serum creatinine level between admission, post-operative and 30-day values was an increase of 0.14 mg/dL and a decrease of 0.11 mg/dL, respectively. Post-operative AKI occurred in the two patients who died. All 6 surviving patients showed sac shrinkage >5 mm, and no reinterventions at a median follow-up of 10 months.</p><p><strong>Conclusions: </strong>Endovascular repair of rAAA with the exclusive use of CO<sub>2</sub> as contrast agent is technically feasible and safe. Further studies are needed to determine whether CO<sub>2</sub> increases survival rate and limits the progression of renal dysfunction after endovascular repair of rAAA.Clinical ImpactThe recorded rate of post-operative AKI after endovascular repair of rAAA performed with the use of CO<sub>2</sub> found in this pilot study was significantly lower than the one reported in the literature with the use of ICM. Our hyphotesis is that the use of CO<sub>2</sub> during rEVAR might increase survival rate and limits the progression of renal dysfunction.</p>","PeriodicalId":50210,"journal":{"name":"Journal of Endovascular Therapy","volume":" ","pages":"498-502"},"PeriodicalIF":1.7000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Pilot Study of Endovascular Repair for Ruptured Aortic Aneurysms With the Use of Carbon Dioxide Angiography Alone.\",\"authors\":\"Gianluca Massaini, Tommaso Lazzarotto, Fabrizio Masciello, Simone Panci, Stefano Michelagnoli, Emiliano Chisci\",\"doi\":\"10.1177/15266028231180995\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Endovascular aortic repair (EVAR) of a ruptured abdominal aortic aneurysm (rAAA) has become a common approach. Hemorrhagic shock associated with the use of iodinated contrast medium (ICM) increases the risk of acute kidney injury (AKI). Theoretically, eliminating ICM from EVAR can decrease that risk. The aim of this pilot study was to analyze the feasibility and safety of emergent EVAR performed with the exclusive use of carbon dioxide (CO<sub>2</sub>) for a rAAA.</p><p><strong>Methods: </strong>Since 2021, all consecutive rAAAs with hemorrhagic shock and suitable anatomical criteria for a standard endograft have been treated by EVAR with the exclusive use of CO<sub>2</sub> using an automated CO<sub>2</sub> injector (Angiodroid SpA, San Lazzaro di Savena, Italy).</p><p><strong>Results: </strong>Eight percutaneous EVARs were performed under local anesthesia. Median age was 78 (interquartile range [IQR]=6) years, 5 patients were male. The technical success was 100%, the 30-day mortality was 25% (n=2), the median amount of administered CO<sub>2</sub> was 400 (IQR=60) ml. The median change in serum creatinine level between admission, post-operative and 30-day values was an increase of 0.14 mg/dL and a decrease of 0.11 mg/dL, respectively. Post-operative AKI occurred in the two patients who died. All 6 surviving patients showed sac shrinkage >5 mm, and no reinterventions at a median follow-up of 10 months.</p><p><strong>Conclusions: </strong>Endovascular repair of rAAA with the exclusive use of CO<sub>2</sub> as contrast agent is technically feasible and safe. Further studies are needed to determine whether CO<sub>2</sub> increases survival rate and limits the progression of renal dysfunction after endovascular repair of rAAA.Clinical ImpactThe recorded rate of post-operative AKI after endovascular repair of rAAA performed with the use of CO<sub>2</sub> found in this pilot study was significantly lower than the one reported in the literature with the use of ICM. Our hyphotesis is that the use of CO<sub>2</sub> during rEVAR might increase survival rate and limits the progression of renal dysfunction.</p>\",\"PeriodicalId\":50210,\"journal\":{\"name\":\"Journal of Endovascular Therapy\",\"volume\":\" \",\"pages\":\"498-502\"},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2025-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Endovascular Therapy\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/15266028231180995\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/6/13 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Endovascular Therapy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/15266028231180995","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/6/13 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
摘要
腹主动脉瘤破裂(rAAA)的血管内主动脉修复(EVAR)已成为一种常见的方法。与使用碘造影剂(ICM)相关的失血性休克增加急性肾损伤(AKI)的风险。理论上,从EVAR中消除ICM可以降低这种风险。本初步研究的目的是分析紧急EVAR的可行性和安全性,在rAAA中只使用二氧化碳(CO2)。方法:自2021年以来,所有连续的伴有出血性休克且符合标准内移植物解剖标准的raaa均采用EVAR治疗,使用自动CO2注射器(Angiodroid SpA, San Lazzaro di Savena,意大利),仅使用CO2。结果:局部麻醉下行经皮EVARs 8例。中位年龄78岁(四分位数间距[IQR]=6)岁,男性5例。技术成功率为100%,30天死亡率为25% (n=2), CO2给药中位数为400 (IQR=60) ml。入院、术后和30天血清肌酐水平变化中位数分别为增加0.14 mg/dL和减少0.11 mg/dL。2例死亡患者发生术后AKI。6例存活患者均出现囊缩> 5mm,中位随访10个月无再干预。结论:单纯使用CO2造影剂进行rAAA血管内修复在技术上是可行且安全的。需要进一步的研究来确定CO2是否能提高rAAA血管内修复后的存活率和限制肾功能障碍的进展。临床影响:本先导研究中使用CO2进行rAAA血管内修复术后AKI的记录率明显低于文献中使用ICM的记录率。我们的假设是,在rEVAR期间使用CO2可能增加生存率并限制肾功能障碍的进展。
A Pilot Study of Endovascular Repair for Ruptured Aortic Aneurysms With the Use of Carbon Dioxide Angiography Alone.
Introduction: Endovascular aortic repair (EVAR) of a ruptured abdominal aortic aneurysm (rAAA) has become a common approach. Hemorrhagic shock associated with the use of iodinated contrast medium (ICM) increases the risk of acute kidney injury (AKI). Theoretically, eliminating ICM from EVAR can decrease that risk. The aim of this pilot study was to analyze the feasibility and safety of emergent EVAR performed with the exclusive use of carbon dioxide (CO2) for a rAAA.
Methods: Since 2021, all consecutive rAAAs with hemorrhagic shock and suitable anatomical criteria for a standard endograft have been treated by EVAR with the exclusive use of CO2 using an automated CO2 injector (Angiodroid SpA, San Lazzaro di Savena, Italy).
Results: Eight percutaneous EVARs were performed under local anesthesia. Median age was 78 (interquartile range [IQR]=6) years, 5 patients were male. The technical success was 100%, the 30-day mortality was 25% (n=2), the median amount of administered CO2 was 400 (IQR=60) ml. The median change in serum creatinine level between admission, post-operative and 30-day values was an increase of 0.14 mg/dL and a decrease of 0.11 mg/dL, respectively. Post-operative AKI occurred in the two patients who died. All 6 surviving patients showed sac shrinkage >5 mm, and no reinterventions at a median follow-up of 10 months.
Conclusions: Endovascular repair of rAAA with the exclusive use of CO2 as contrast agent is technically feasible and safe. Further studies are needed to determine whether CO2 increases survival rate and limits the progression of renal dysfunction after endovascular repair of rAAA.Clinical ImpactThe recorded rate of post-operative AKI after endovascular repair of rAAA performed with the use of CO2 found in this pilot study was significantly lower than the one reported in the literature with the use of ICM. Our hyphotesis is that the use of CO2 during rEVAR might increase survival rate and limits the progression of renal dysfunction.
期刊介绍:
The Journal of Endovascular Therapy (formerly the Journal of Endovascular Surgery) was established in 1994 as a forum for all physicians, scientists, and allied healthcare professionals who are engaged or interested in peripheral endovascular techniques and technology. An official publication of the International Society of Endovascular Specialists (ISEVS), the Journal of Endovascular Therapy publishes peer-reviewed articles of interest to clinicians and researchers in the field of peripheral endovascular interventions.